BUCHAREST (Romania), February 2 (SeeNews) – Austria's Erste group said on Wednesday it upgraded its recommendation for Romanian drug maker Antibiotice [BSE:ATB] to 'Accumulate' from 'Hold' and raised the target price for the stock by 13%.